PBMs, Formularies, and Rebates: What Investors Should Know

There is no simple way to explain drug prices, particularly in the US market, where drug prices vary considerably more than they do in other countries. Most Americans are familiar…
The post PBMs, Formularies, and Rebates: What Investors Should Know app…


The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

This article was originally published by Gerard T. Vondeling, Qi Cao, Maarten J. Postma, and Mark H. Rozenbaum in Applied Health Economics and Health Policy (2018) pp.1-8 under a Creative Commons Attribution-NonCommercial…
The post The Impact of Patent…


Clause 8 Podcast Interview with Co-Author of the Hatch-Waxman Act

Former Congressman Henry Waxman was recently interviewed for the Clause 8 podcast about how he worked together with Sen. Orrin Hatch to pass the Hatch-Waxman Act and its aftermath.  Congressman…
The post Clause 8 Podcast Interview with Co-Author of the…


3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges

This paper was originally published by Witold Jamróz, Joanna Szafraniec, Mateusz Kurek, and Renata Jachowicz in Pharmaceutical Research September 2018, 35:176 under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/li…


Orphan Drug Patents: Concerns Raised by Payers and Policy Makers

There are more than 7,000 diseases that are considered “rare,” that is, affecting fewer than 200,000 Americans. Yet around one in ten Americans lives with at least one of these…
The post Orphan Drug Patents: Concerns Raised by Payers and Policy Makers …


Why Generic Drug Makers May Benefit from 505(b)(2) Approval

A few years ago, there was much talk of the “patent cliff” facing blockbuster drugs like Lipitor and other huge name-brand drugs. The “patent cliff” may have spelled the end…
The post Why Generic Drug Makers May Benefit from 505(b)(2) Approval appeared…


Patenting human genes: Chinese academic articles’ portrayal of gene patents

This article was originally published by Li Du in BMC Medical Ethics 2018 19:29 under a creative commons license. Abstract Background The patenting of human genes has been the subject…
The post Patenting human genes: Chinese academic articles’ portraya…


The 505(b)(2) Drug Patent Approval Process: Uses and Potential Advantages

Drug development is one of the world’s most high-risk / high-reward industries, with the vast majority of drugs created never making it to market. Of those that do make it…
The post The 505(b)(2) Drug Patent Approval Process: Uses and Potential Advanta…


Pharmaceutical Portfolio Management Reading List

Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly…
The post Pharmaceutical Portfo…


How Artificial Intelligence Will Affect Healthcare and Drug Prices

Artificial intelligence (AI) is the development within computer systems of the ability to perform tasks that have traditionally required human intelligence. Examples of AI applications include visual perception, speech recognition,…
The post How Artifi…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: